

[ Fri, Jun 21st 2024
] - WOPRAI
[ Fri, Jun 21st 2024
] - WOPRAI
[ Fri, Jun 21st 2024
] - WOPRAI
[ Fri, Jun 21st 2024
] - WOPRAI
[ Fri, Jun 21st 2024
] - WOPRAI
[ Fri, Jun 21st 2024
] - WOPRAI
[ Fri, Jun 21st 2024
] - WOPRAI
[ Fri, Jun 21st 2024
] - WOPRAI
[ Fri, Jun 21st 2024
] - WOPRAI
[ Fri, Jun 21st 2024
] - WOPRAI
[ Fri, Jun 21st 2024
] - WOPRAI
[ Fri, Jun 21st 2024
] - WOPRAI
[ Fri, Jun 21st 2024
] - WOPRAI
[ Fri, Jun 21st 2024
] - WOPRAI
[ Fri, Jun 21st 2024
] - WOPRAI
[ Fri, Jun 21st 2024
] - WOPRAI
[ Fri, Jun 21st 2024
] - WOPRAI
[ Fri, Jun 21st 2024
] - WOPRAI
[ Fri, Jun 21st 2024
] - WOPRAI
[ Fri, Jun 21st 2024
] - WOPRAI
[ Fri, Jun 21st 2024
] - WOPRAI
[ Fri, Jun 21st 2024
] - WOPRAI

[ Thu, Jun 20th 2024
] - WOPRAI
[ Thu, Jun 20th 2024
] - WOPRAI
[ Thu, Jun 20th 2024
] - WOPRAI
[ Thu, Jun 20th 2024
] - WOPRAI
Alethia Young Reiterated (ARWR) at Buy on, Jun 20th, 2024
Alethia Young of Cantor Fitzgerald, Reiterated "Arrowhead Pharmaceuticals, Inc." (ARWR) at Buy on, Jun 20th, 2024.
Alethia has made no other calls on ARWR in the last 4 months.
There are 4 other peers that have a rating on ARWR. Out of the 4 peers that are also analyzing ARWR, 2 agree with Alethia's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Andrea Tan of "Goldman Sachs" Initiated at Hold and Held Target at $31 on, Wednesday, June 5th, 2024
- Michael Ulz of "Morgan Stanley" Maintained at Hold with Decreased Target to $27 on, Monday, May 13th, 2024
These are the ratings of the 2 analyists that currently disagree with Alethia
- Patrick Trucchio of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $90 on, Tuesday, June 11th, 2024
- Keay Nakae of "Chardan Capital" Maintained at Strong Buy and Held Target at $60 on, Monday, June 3rd, 2024
Contributing Sources